Login / Signup

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

Devendra K HiwaseChristopher N HahnElizabeth Ngoc Hoa TranRakchha ChhetriAnmol BaranwalAref A Al-KaliKirsty SharplinDariusz LadonRachel HollinsPatricia T GreippMonika KutynaHassan AlkhateebTalha BadarPaul WangDavid Morrall RossDeepak SinghalNaranie ShanmuganathanPeter BardyAshanka BeligaswatteDavid YeungMark R LitzowAbhishek MangaonkarPratyush GiriCindy LeeAngie YongNoemi HorvathNimit SinghalRaghu GowdaWilliam HoganNaseema GangatMirinal S PatnaikKebede H BegnaIng Soo TiongAndrew H WeiSharad KumarAnna L BrownHamish S ScottDaniel ThomasChung H KokAyalew TefferiMithun Vinod Shah
Published in: Blood (2023)
Keyphrases
  • dendritic cells
  • bone marrow
  • acute myeloid leukemia
  • low grade
  • single molecule
  • stem cells
  • immune response
  • mesenchymal stem cells
  • drug induced